Fortis Healthcare has sought approval from the Competition Commission of India to acquire an additional 31.52% stake in its diagnostics arm, Agilus, raising its shareholding to 89.2%. The deal, valued at ₹1,780 crore, involves buying stakes from private equity players. Additionally, Aquilo House Pte seeks approval to acquire a 26.47% stake in Aavas Financiers.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/d1TNWH4
via IFTTT
Home »
Healthcare/Biotech-Industry-Economic Times
» Fortis seeks CCI nod to buy 31.52% more in diagnostics subsidiary Agilus
0 comments:
Post a Comment